GATTA, LUIGI
 Distribuzione geografica
Continente #
AS - Asia 3.131
NA - Nord America 2.947
EU - Europa 1.414
SA - Sud America 228
Continente sconosciuto - Info sul continente non disponibili 135
AF - Africa 86
OC - Oceania 2
Totale 7.943
Nazione #
US - Stati Uniti d'America 2.885
VN - Vietnam 921
SG - Singapore 884
CN - Cina 683
HK - Hong Kong 338
IT - Italia 329
GB - Regno Unito 275
BR - Brasile 164
DE - Germania 163
SE - Svezia 148
FR - Francia 109
RU - Federazione Russa 74
IN - India 73
UA - Ucraina 73
FI - Finlandia 46
BD - Bangladesh 44
NL - Olanda 44
BG - Bulgaria 43
IE - Irlanda 43
CA - Canada 36
JP - Giappone 36
ZA - Sudafrica 29
CI - Costa d'Avorio 23
ID - Indonesia 21
JO - Giordania 20
AR - Argentina 19
EE - Estonia 17
KR - Corea 17
TH - Thailandia 17
SC - Seychelles 15
PH - Filippine 13
CO - Colombia 9
EC - Ecuador 9
MX - Messico 9
MY - Malesia 9
PL - Polonia 9
SA - Arabia Saudita 9
BE - Belgio 8
ES - Italia 8
IQ - Iraq 8
PY - Paraguay 8
TG - Togo 7
TW - Taiwan 7
PK - Pakistan 6
TR - Turchia 6
CL - Cile 5
GR - Grecia 5
KE - Kenya 5
PE - Perù 5
AT - Austria 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
BO - Bolivia 3
IR - Iran 3
LT - Lituania 3
NP - Nepal 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BS - Bahamas 2
CG - Congo 2
CZ - Repubblica Ceca 2
EG - Egitto 2
LU - Lussemburgo 2
PS - Palestinian Territory 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
SR - Suriname 1
TT - Trinidad e Tobago 1
Totale 7.810
Città #
Singapore 544
Hong Kong 323
San Jose 290
Ashburn 273
Santa Clara 251
Southend 231
Ho Chi Minh City 229
Hanoi 194
Chandler 162
Fairfield 152
Boardman 106
Beijing 93
Wilmington 72
Council Bluffs 69
Princeton 68
Seattle 61
Woodbridge 60
Houston 57
Hefei 52
Cambridge 49
New York 47
Helsinki 46
Los Angeles 46
Jacksonville 45
Ann Arbor 44
Nanjing 44
Dublin 43
Sofia 43
Dong Ket 42
Da Nang 35
Rome 34
Lauterbourg 32
Dallas 30
Tokyo 30
Haiphong 29
Jinan 29
Padova 27
Westminster 27
Abidjan 23
Milan 21
Shanghai 21
Amman 20
Buffalo 20
Orem 20
Berlin 19
Biên Hòa 19
Bologna 19
Falkenstein 18
Frattamaggiore 18
Frankfurt am Main 17
San Francisco 15
Shenyang 15
Can Tho 14
Mountain View 14
Guangzhou 13
Nanchang 13
Phoenix 13
San Diego 13
Turin 13
Hebei 12
Hải Dương 12
Mülheim 12
Seoul 12
Tianjin 12
Atlanta 11
Changsha 11
Chicago 11
Saint Petersburg 11
Montreal 10
Bangkok 9
Bari 9
São Paulo 9
Chennai 8
Ha Long 8
Shenzhen 8
Taizhou 8
Tappahannock 8
Zhengzhou 8
Brussels 7
Bắc Ninh 7
Chengdu 7
Denver 7
Fort Worth 7
Lomé 7
Naples 7
Redwood City 7
Shijiazhuang 7
Thái Nguyên 7
Vũng Tàu 7
Warsaw 7
Brooklyn 6
Bắc Giang 6
Curitiba 6
Haikou 6
Jakarta 6
Kunming 6
Lanzhou 6
Medford 6
Phủ Lý 6
Porto Alegre 6
Totale 4.700
Nome #
Effetti avversi gastrointestinali: farmaci anti-infiammatori non steroidei ed Helicobacter pylori 241
Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial 233
Review article: Invasive and non-invasive tests for Helicobacter pylori infection 232
Epidemiologia dell’Infezione da Helicobacter pylori e Cancro gastrico non cardiale. Insegnamenti per il futuro. 218
A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire 213
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses 210
Diagnosi non invasiva e terapia per Helicobacter Pylori 209
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 203
A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment 201
E-test for Metronidazole Susceptibility Q1 in H pylori: Use of the Wrong Standard May Have Led to the Wrong Conclusion: Reply 194
Gastroesophageal Reflux Disease and Barrett’s Esophagus 191
Diagnosi dell’infezione da Helicobacter pylori 181
Helicobacter pylori eradication: Are we really all equal? A controlled study in native and immigrant population 176
Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease 171
Quantification of Serum Levels of Pepsinogens and Gastrin to Assess Eradication of Helicobacter Pylori 163
Peptic ulcer and Helicobacter pylori. 161
Proton pump inhibitors and antiplatelet drugs in clinical cardiology. 159
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children. 158
Probiotici ricombinanti e loro potenziale sulla salute umana 153
Global eradication rates for helicobacter pylori infection: systematic review and meta-analysis of sequantial therapy 150
Le molecole strutturali batteriche come potenziali candidate per l’evoluzione del concetto classico di probiotici. 147
Recombinant probiotics and their potential in human health 145
High Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study 144
Treatment of Helicobacter Pylori in Latin America 141
Valutazione di economia sanitaria sull’infezione da Helicobacter pylori. 137
Best Cut-Off Values for [14C]-Urea Breath Tests for Helicobacter pylori Detection 134
The stool antigen test for detection of Helicobacter pylori after eradication therapy 133
Sequential therapy for H. pylori: an “aberrant” therapy ready for general use. 132
Errors in a meta-analysis of treatment for Helicobacter pylori infection 124
Peroxisome proliferators activated receptors gamma and the inflammatory state of gastric mucosa 101
Newer agents for Helicobacter pylori eradication 93
null 83
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: A randomized trial 79
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 76
Diagnostic accuracy of a new rapid urease test (Pronto Dry) before and after treatment of Helicobacter pylori infection 71
Non-invasive analyses for the diagnosis of Helicobacter pylori infection. A critical review of the literature 71
The clinical role of cytochrome P450 genotypes in Helicobacter pylori management 66
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: A randomized trial 65
A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment 64
Non-invasive analyses for the diagnosis of Helicobacter pylori infection. A critical review of the literature 62
Best Cut-Off Values for [14C]-Urea Breath Tests for Helicobacter pylori Detection 62
Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori 60
Review article: The transmission of Helicobacter pylori from stomach to stomach 59
Peptic ulcer and Helicobacter pylori: Update on testing and treatment 58
The clinical role of cytochrome P450 genotypes in Helicobacter pylori management 57
Peptic ulcer and Helicobacter pylori: Update on testing and treatment 55
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 54
High eradication rates of Helicobacter pylori with a new sequential treatment 53
Review article: The transmission of Helicobacter pylori from stomach to stomach 53
The stool antigen test for detection of Helicobacter pylori after eradication therapy 53
High eradication rates of Helicobacter pylori with a new sequential treatment 53
Helicobacter pylori infection: Anything new should we know? 50
New immunological assays for the diagnosis of Helicobacter pylori infection 48
Accurate diagnosis of helicobacter pylori stool tests 48
Peptic ulcer and Helicobacter pylori 47
Helicobacter pylori infection: Anything new should we know? 43
Esophagitis and gastroesophageal reflux 42
Review article: Invasive and non-invasive tests for Helicobacter pylori infection 41
Review article: Diagnosis and treatment of Helicobacter: A 2002 updated review 41
Diagnostic accuracy of a new rapid urease test (Pronto Dry) before and after treatment of Helicobacter pylori infection 40
Therapeutics news on Helicobacter pylori and clarithromycin from Budapest, Wien and Helsinki 38
Susceptibility of Helicobacter pylori to Metronidazole 38
Blood tests in the management of Helicobacter pylori infection 36
Review article: Helicobacter pylori infection from pathogenesis to treatment - A critical reappraisal 36
Review article: Helicobacter pylori infection from pathogenesis to treatment - A critical reappraisal 35
Review article: Diagnosis of Helicobacter pylori infection 35
Blood tests in the management of Helicobacter pylori infection 35
Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects 34
Susceptibility of Helicobacter pylori to Metronidazole 32
Routes of trasmission of Helicobacter pylori infection 32
Treatment of Helicobacter pylori 32
Review article: Diagnosis and treatment of Helicobacter: A 2002 updated review 31
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment [7] 31
A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment 30
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment [7] 29
Absence of Helicobacter pylori in dental plaque assessed by stool test [19] 27
Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori 26
Therapeutics news on Helicobacter pylori and clarithromycin from Budapest, Wien and Helsinki 26
Symptoms and Helicobacter pylori: Any link [6] 25
Clinical role of fecal antigen determination in the diagnosis of Helicobacter pylori infection 25
Diagnosis of Helicobacter pylori infection: Which is the best test? The stool test 24
Symptoms and Helicobacter pylori: Any link [6] 24
Review article: Diagnosis of Helicobacter pylori infection 23
Therapeutic news on Helicobacter pylori from Budapest and Wien 22
Clinical role of fecal antigen determination in the diagnosis of Helicobacter pylori infection 22
Treatment of Helicobacter pylori 22
Isotope ratio mass spectrometry (IRMS) versus laser-assisted ratio analyzer (LARA): A comparative study using two doses of [13C]urea and two test meals for pre- and posttreatment diagnosis of Helicobacter pylori infection 21
Helicobacter pylori: Diseases, tests and treatment 20
Therapeutic news on Helicobacter pylori from Budapest and Wien 20
Helicobacter pylori seroconversion in asymptomatic blood donors: A five-year follow-up 20
Routes of trasmission of Helicobacter pylori infection 19
Isotope ratio mass spectrometry (IRMS) versus laser-assisted ratio analyzer (LARA): A comparative study using two doses of [13C]urea and two test meals for pre- and posttreatment diagnosis of Helicobacter pylori infection 18
Noninvasive tests to diagnose Helicobacter pylori infection 17
Helicobacter pylori infection, anti-cagA antibodies and peptic ulcer: A case-control study in italy 16
How valuable is the application on consensus guidelines in the management of functional gastrointestinal disorders? 16
Helicobacter pylori infection, anti-cagA antibodies and peptic ulcer: A case-control study in italy 16
Non-invasive techniques for the diagnosis of Helicobacter pylori infection 16
Noninvasive tests to diagnose Helicobacter pylori infection 16
Non-invasive techniques for the diagnosis of Helicobacter pylori infection 15
The clinical role of extracellular bioimpedance tomography (Gastro-Midax®) in the diagnosis of colorectal diseases 14
Totale 7.916
Categoria #
all - tutte 24.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022499 0 19 27 56 50 18 4 33 15 17 172 88
2022/2023568 70 86 53 62 19 42 16 26 114 15 47 18
2023/2024404 95 44 36 73 37 70 12 2 6 10 5 14
2024/20251.544 39 176 81 94 416 69 95 53 15 67 27 412
2025/20263.246 392 184 273 247 335 155 199 289 580 287 126 179
2026/2027308 168 140 0 0 0 0 0 0 0 0 0 0
Totale 7.943